Navigation Links
Voice Biometrics Gains Traction as Most Accurate and Convenient Technology to Secure Customer Privacy
Date:9/3/2007

Largest Consumer Deployment Reaches 275,000 Enrollment Milestone

NEW YORK, Aug. 20 /PRNewswire/ -- This week at SpeechTEK, the voice solutions showcase, PerSay, the leader in voice biometrics, will demonstrate how its VocalPassword technology powers Bell's Voice Identification Service. Bell, the largest communications provider in Canada, has made a spoken pass phrase the universal identifier for customer support across five service segments (wireline, wireless, high-speed Internet, digital TV and VoIP). Voluntary enrollment is offered to customers as a more convenient alternative to an array of PIN-based services and manual authentication methods, with voice biometrics supporting the company's ongoing commitment to protect privacy as it offers increasingly complex and varied services.

PerSay VocalPassword was selected for the Bell project in September 2006. Installation, integration by IBM Global Business Services, and testing followed quickly, and beginning in March, Bell's Voice Identification Service was rolled out, one area code at a time, to all wireline and wireless customers in Canada. As of August 20, 2007, Bell reported more than 275,000 voluntary enrollments.

Bell has a long-standing reputation for its leadership in the protection of the privacy and security of customers' personal information. So, the introduction of any identity authentication system had to align with Bell's privacy policy without exception. It had to be secure, simple and user- friendly, with customer trust as the most crucial element. PerSay brought the depth of experience built on numerous successful deployments that positioned it as the service provider of choice for a voice authentication solution guaranteed to comply with Bell's privacy policy. "The primary driver for Bell in implementing a voice verification system was to make privacy protection more convenient for Bell customers," explained Charles Giordano, marketing lead for the company's voice authen
'/>"/>

SOURCE PerSay
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
2. Bound for destruction: Ubiquitination protects against improper Notch signaling
3. Female sex hormones play a vital role in defense against sexually transmitted diseases
4. In the sea slugs defense against lobsters, confusion is key
5. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
6. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
7. Antibodies from plants protect against anthrax
8. Mayo Clinic Researchers Create Obedient Virus; First Step To Use Measles Virus Against Cancer
9. Molecular models advance the fight against malaria
10. Researchers make gains in understanding antibiotic resistance
11. Sickle cell and protection against malaria

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... matter of debate. A high-profile study a few year... their carbon from trees and leaves, evidence for ...tic ecosystems. , But new research from the Univ...e true. Algae provide a much richer diet for fish ...ished this week in the Proceedings of the Nationa...
(Date:11/23/2009)...associated strain of the deadly superbug MRSAan in...antibioticsposes a far greater health threat than ...als, according to a study in the December issue of...at is easily picked up in fitness centers, schools...erall burden of MRSA within hospitals, the report ...
(Date:11/23/2009)...participants gathered this week for the seventh an...nference. This year,s topic, "Synthetic Biology," ...l researchers to explore the engineering, scientif...ld of synthetic biology. , Bonnie L. Bassler, pr...ty and this year,s conference chair, challenged th...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Quest Diagnostics Commences Cash Tender Offer for Any and All of Certain of its Outstanding Notes 6203 1Quest Diagnostics Commences Cash Tender Offer for Any and All of Certain of its Outstanding Notes 6203 2Quest Diagnostics Commences Cash Tender Offer for Any and All of Certain of its Outstanding Notes 6203 3Quest Diagnostics Commences Cash Tender Offer for Any and All of Certain of its Outstanding Notes 6203 4Orexigen 28R 29 Therapeutics to Speak at Lazard Capital Markets Healthcare Conference 6198 1Behavior modification could ease concerns about nanoparticles 10701 1Behavior modification could ease concerns about nanoparticles 10701 2
...g, Va. -- A veterinary neurologist on faculty in t...y Medicine( www.vetmed.vt.edu ) at Virginia Tech h...rsity Translational Science Institute to study inn...gs, cats and humans. , Dr. John Rossmeisl, an ass... Clinical Sciences (DSACS), is working with Wake F...
...gian Tooth Bank is requesting milk teeth from 100 ...t tooth bank in the world. Milk teeth can give un...d nutrition in the foetus and in early childhood. ...Mother and Child Cohort Study (MoBa), and is a col... of Public Health and the University of Bergen. ,...
...e earliest general anaesthetics to be used by the ...a mystery thats puzzled doctors for more than 150 ...iscovery described as true serendipity made by Lee...ovided a clue that may unravel the enigma of gener...n new generations of anaesthetics without harmful ...
Other Biology News:Veterinary college researcher studying brain tumors in people and animals 2Veterinary college researcher studying brain tumors in people and animals 3Tooth Bank seeks milk teeth from 100,000 children 2Chloroform provides clue to 150 year old medical puzzle 2
(Date:11/24/2009)...YKJAVIK, Iceland, November 24 /PRNewswire-FirstCal...announced the approval of all of its,"first day" m...ct of Delaware,(the "Bankruptcy Court"). deCODE la...r Chapter 11 of the United States Bankruptcy Code ...ssued by the Bankruptcy Court allow the company to...
(Date:11/24/2009)...re/--BlueMarbleEnergyCorp.announcedtodaythatthecom...rerecentlyawarded$2millionbyWashingtonState,sCommu...blicpartnershiptoconstructthestate,sfirstspecialty...hisinvestmentwillsignificantlyspeedthedevelopmento...nty,"saidBlueMarbleEnergyCEOKellyOgilvie."Wearegra...
(Date:11/24/2009)...er 24 Shire plc (LSE: SH...aceutical company, today,announced that it has sub...velaglucerase alfa, the company,s enzyme replaceme...e 1 Gaucher disease. This is the third marketing,a...bmitted, with previous,submissions in the United S...
(Date:11/24/2009)...am Connects Customers with Partners Validated to P...tek Products , Ottawa, ON...ding provider of products for biological sample co...ounced its new global partner program. The program... partner community and is designed to help partner...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...lvania and OXFORD, England, May 9 ,EUSA Pharma Inc...l company,focused on oncology, pain control and cr... its acquisition of Cytogen Corporation, following...al meeting on 8 May., Under the terms of the acqu...ve $0.62 per share, valuing the company at $22.6 m...
...CAMBRIDGE, Mass., May 9 ,Takeda Pharmaceutical Com...,Pharmaceuticals, Inc., "Millennium" (Nasdaq: MLN...akeda,s cash tender offer by its wholly-owned,subs... outstanding shares,of Millennium common stock for... for the tender offer expired at 12:00,midnight, N...
...Arena Pharmaceuticals, Inc.,(Nasdaq: ARNA ) annou...t at,the Bank of America 2008 Healthcare Conferenc...p.m. Eastern Time) at the Four Seasons Hotel in La...Senior Vice President and,Chief Scientific Officer...ny, including its clinical development and discove...
Other Biology Technology:EUSA Pharma Completes Acquisition Of Cytogen Corporation 2EUSA Pharma Completes Acquisition Of Cytogen Corporation 3Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 2Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 3Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 4Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 5Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference 2Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference 3
Bulk Enzymes/Bulk Proteins from Molecular Biology Resources
SlideHyb™ Glass Array Hybridization Survey Kit from Ambion
GeneTraffic from Iobion Informatics
...ial data collection and automation that is control...ration with Microsoft Excel , Pre-configured libr...rs, density meters, force gauges, spectrophotomete... added and configured by the user , Collect data...
Biology Products: